[
  {
    "variant_id": {
      "Gene": "BRCA1",
      "Protein_Change": {
        "ref": "L",
        "alt": "R",
        "position": "152"
      },
      "variant_string_id": "BRCA1 L152R"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that BRCA1 is involved in DNA repair and homologous recombination. The L152R mutation disrupts this function, leading to reduced DNA repair efficiency.",
        "judgment": "Yes",
        "reasoning": "The disease mechanism is clearly defined as a disruption in DNA repair due to the mutation."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "An allele-specific enzyme activity assay was used to measure DNA repair efficiency in patient fibroblasts.",
        "judgment": "Yes",
        "reasoning": "The assay directly measures DNA repair efficiency, which is relevant to the disease mechanism."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls (normal and mutant alleles) and replicates were used. The study included multiple experiments in triplicate.",
        "judgment": "Yes",
        "reasoning": "Both basic controls and replicates were included, so the assay is valid."
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "Known pathogenic variants were used as controls.",
        "judgment": "Yes",
        "reasoning": "Variant controls (known pathogenic) were included in the assay."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The functional evidence supports that L152R is a likely pathogenic variant based on reduced DNA repair efficiency compared to controls."
  },
  {
    "variant_id": {
      "Gene": "BRCA1",
      "Protein_Change": {
        "ref": "F",
        "alt": "I",
        "position": "49"
      },
      "variant_string_id": "BRCA1 F49I"
    },
    "functional_evidence_aim": "Benign",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "The paper states that BRCA1 is involved in DNA repair and homologous recombination. The F49I mutation disrupts this function.",
        "judgment": "Yes",
        "reasoning": "The disease mechanism is clearly defined as a disruption in DNA repair due to the mutation."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "A cell viability assay was used in patient-derived cells with and without the F49I mutation.",
        "judgment": "Yes",
        "reasoning": "The assay measures cell viability, which is relevant to the disease mechanism."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls (normal and mutant alleles) and replicates were used. The study included multiple experiments in triplicate.",
        "judgment": "Yes",
        "reasoning": "Both basic controls and replicates were included, so the assay is valid."
      },
      {
        "step_name": "Sub-step 3c: Variant Controls",
        "extracted_paper_info": "Known benign variants were used as controls.",
        "judgment": "Yes",
        "reasoning": "Variant controls (known benign) were included in the assay."
      }
    ],
    "final_evidence_strength": {
      "type": "Benign",
      "strength": "BS3_supporting"
    },
    "overall_conclusion": "The functional evidence supports that F49I is a likely benign variant based on no significant difference in cell viability compared to controls."
  }
]